PG vs PLRX · P/E 25, rev $84.28B vs $77.3M cap
Procter & Gamble Company (PG) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the PG and PLRX stock pages for the full models.
Not investment advice.